Expert regulatory and market access consultation services for Pakistani pharmaceutical exporters.
Consultation with DRAP, WHO, FDA, and EU regulatory specialists
Country-specific market entry strategies for 80+ destinations
Pre-submission dossier review to identify gaps before filing
Accurate cost and timeline estimation for regulatory approvals
TDAP's Pharma Consultation Service provides Pakistani manufacturers with access to a panel of regulatory consultants who have experience with DRAP, WHO, US-FDA, EMA, MHRA, and other major regulatory authorities. Consultations are available for product registration, GMP compliance, quality system development, and pharmacovigilance requirements.
Our consultants help manufacturers develop market-specific entry strategies, including regulatory pathway selection, local partner identification, pricing strategy, and documentation requirements. Country-specific dossier templates and regulatory intelligence briefs are available to registered portal users.
Registered companies can submit consultation requests through the portal after logging in. Specify the target market, product category, and nature of the consultation required. A TDAP facilitation officer will schedule a consultation session within 5 business days. Initial consultations are subsidized for TDAP-registered exporters.